Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection

Clinical trial NCT04627233 · UNKNOWN

Trial details

NCT number: NCT04627233
Sponsor: Shahid Beheshti University of Medical Sciences
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Covid19 Treatment Corona Virus Infection

Start date: 2020-12-20
Primary completion: 2021-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.